Scott Nicholas Furlan, MD
On staff since December 2015
Academic Title: Acting Instructor
"I am driven to improve the therapy of cancer and blood disorders in children not only with thoughtful research, but also by accompanying patients and their families through the daily triumphs and struggles of their journey, one-by-one."
Furlan SN, Watkins B, Tkachev V, Flynn R, Cooley S, Ramakrishnan S, Singh K, Giver C, Hamby K, Stempora L, Garrett A, Chen J, Betz KM, Ziegler CG, Tharp GK, Bosinger SE, Promislow DE, Miller JS, Waller EK, Blazar BR, Kean LSTranscriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.
26606970 Science translational medicine, 2015 Nov. 25 : 7(315)315ra191
Furlan SN, Mandraju R, Brewer T, Roybal K, Troutman TD, Hu W, Palm NW, Unni A, Pasare CEnhancement of anti-tumor CD8 immunity by IgG1-mediated targeting of Fc receptors.
24284965 mAbs, 2014 Jan. : 6(1)108-18 PMCID:PMC3929435
- Board Certification(s)
- Medical/Professional School
Keck School of Medicine at USC, Los Angeles
Pediatrics, UT Southwestern Medical School, Dallas
Pediatric Hematology Oncology, UT Southwestern Medical Center, Dallas
Seattle Children's Research Institute, Seattle
- Clinical Interests
Hematopoietic cell transplantation, graft-versus-host disease, transplant immunology, cellular therapies
- Research Description
Genomics, immunology, molecular biology